CD1D: Difference between revisions
Jump to navigation
Jump to search
imported>KolbertBot m (Bot: HTTP→HTTPS (v485)) |
|||
| Line 1: | Line 1: | ||
{{Infobox_gene}} | {{Infobox_gene}} | ||
'''CD1D''' is the [[human]] [[gene]] that encodes the [[protein]] '''CD1d''',<ref name="P15813 CD1D_HUMAN">{{cite web|title=P15813 (CD1D_HUMAN)|url= | '''CD1D''' is the [[human]] [[gene]] that encodes the [[protein]] '''CD1d''',<ref name="P15813 CD1D_HUMAN">{{cite web|title=P15813 (CD1D_HUMAN)|url=https://www.uniprot.org/uniprot/P15813|publisher=Uniprot|accessdate=1 March 2013}}</ref> a member of the [[CD1]] (cluster of differentiation 1) family of [[glycoprotein]]s expressed on the surface of various human [[antigen-presenting cell]]s. They are non-classical MHC proteins, related to the [[class I MHC]] proteins, and are involved in the presentation of lipid [[antigens]] to [[T cells]]. CD1d is the only member of the group 2 CD1 molecules. | ||
==Biological significance== | ==Biological significance== | ||
| Line 12: | Line 12: | ||
==Ligands== | ==Ligands== | ||
Some of the known ligands for CD1d are: | Some of the known ligands for CD1d are: | ||
* [[Fatty acid#Nomenclature|α]]-[[galactosylceramide]] (α-GalCer), a compound originally derived from the marine sponge ''[[Agelas]] mauritanius''<ref>{{cite journal|first=Richard W.|last=Franck|title=C-Galactosylceramide: Synthesis and Immunology|journal= | * [[Fatty acid#Nomenclature|α]]-[[galactosylceramide]] (α-GalCer), a compound originally derived from the marine sponge ''[[Agelas]] mauritanius''<ref>{{cite journal|first=Richard W.|last=Franck|title=C-Galactosylceramide: Synthesis and Immunology|journal=Comptes Rendus Chimie|date=1 January 2012|volume= 15|number=1|pages=46–56|pmc=3293403|doi=10.1016/j.crci.2011.05.006|pmid=22408579}}</ref> with no physiological role but great research utility. | ||
* α-[[glucuronic acid|glucuronyl-]] and α-[[Galacturonic acid|galacturonyl-]] [[ceramides]], a family of compounds of microbial origin which can be found, for example, on the [[cell wall]] of ''[[Sphingomonas]]'', a ubiquitous [[Gram-negative]] [[bacterium]].<ref>{{cite journal|last=Bendelac|first=A|author2=Savage PB|author3=Teyton I|title=The Biology of NKT Cells|journal=Annual Review of Immunology|doi=10.1146/annurev.immunol.25.022106.141711|pmid= 17150027|volume=25|year=2007|pages=297–336|issue=1}}<!--|accessdate=5 March 2013--></ref> The related β-D-[[glucose|glucopyranosyl]]ceramide is accumulated in [[antigen-presenting cells]] after infection, where it serves to activate [[invariant NKT]]s (iNKTs), a special kind of NKT. | * α-[[glucuronic acid|glucuronyl-]] and α-[[Galacturonic acid|galacturonyl-]] [[ceramides]], a family of compounds of microbial origin which can be found, for example, on the [[cell wall]] of ''[[Sphingomonas]]'', a ubiquitous [[Gram-negative]] [[bacterium]].<ref>{{cite journal|last=Bendelac|first=A|author2=Savage PB|author3=Teyton I|title=The Biology of NKT Cells|journal=Annual Review of Immunology|doi=10.1146/annurev.immunol.25.022106.141711|pmid= 17150027|volume=25|year=2007|pages=297–336|issue=1}}<!--|accessdate=5 March 2013--></ref> The related β-D-[[glucose|glucopyranosyl]]ceramide is accumulated in [[antigen-presenting cells]] after infection, where it serves to activate [[invariant NKT]]s (iNKTs), a special kind of NKT. | ||
* [[iGb3]], a self antigen which has been implied in iNKT selection.<ref>{{cite journal|last=Zhou|first=D|title=The immunological function of iGb3|journal=Current Protein & Peptide Science|date=August 2006|volume=7|issue=4|pages= | * [[iGb3]], a self antigen which has been implied in iNKT selection.<ref>{{cite journal|last=Zhou|first=D|title=The immunological function of iGb3|journal=Current Protein & Peptide Science|date=August 2006|volume=7|issue=4|pages=325–33|pmid=16918447|doi=10.2174/138920306778018007}}</ref> | ||
* HS44, a synthetic amino [[cyclitol]]ic ceramide analogue which has less contact with the TCR, activating iNKTs in a more constrained way than α-GalCer (specially in relation to Th2 cytokines production) and thus being more interesting for therapeutic use.<ref>{{cite journal|author=J. Kerzerho|author2= E. Yu|author3=C. M. Barra|author4=E. Alari-Pahissa|author5=E. Girardi|author6=Y. Harrak|author7=P. Lauzurica|author8=A. Llebaria|author9=D. Zajonc|author10=O. Akbari|author11=A. R. Castaño|title=Structural and functional characterization of a novel non-glycosidic iNKT agonist with immunomodulatory properties|journal=Journal of Immunology|year=2012|volume= 188|pages= 2254–2265|pmid= 22301545|doi=10.4049/jimmunol.1103049|pmc=3288653}}</ref> | * HS44, a synthetic amino [[cyclitol]]ic ceramide analogue which has less contact with the TCR, activating iNKTs in a more constrained way than α-GalCer (specially in relation to Th2 cytokines production) and thus being more interesting for therapeutic use.<ref>{{cite journal|author=J. Kerzerho|author2= E. Yu|author3=C. M. Barra|author4=E. Alari-Pahissa|author5=E. Girardi|author6=Y. Harrak|author7=P. Lauzurica|author8=A. Llebaria|author9=D. Zajonc|author10=O. Akbari|author11=A. R. Castaño|title=Structural and functional characterization of a novel non-glycosidic iNKT agonist with immunomodulatory properties|journal=Journal of Immunology|year=2012|volume= 188|pages= 2254–2265|pmid= 22301545|doi=10.4049/jimmunol.1103049|pmc=3288653}}</ref> | ||
Latest revision as of 06:55, 23 March 2018
| VALUE_ERROR (nil) | |||||||
|---|---|---|---|---|---|---|---|
| Identifiers | |||||||
| Aliases | |||||||
| External IDs | GeneCards: [1] | ||||||
| Orthologs | |||||||
| Species | Human | Mouse | |||||
| Entrez |
|
| |||||
| Ensembl |
|
| |||||
| UniProt |
|
| |||||
| RefSeq (mRNA) |
|
| |||||
| RefSeq (protein) |
|
| |||||
| Location (UCSC) | n/a | n/a | |||||
| PubMed search | n/a | n/a | |||||
| Wikidata | |||||||
| |||||||
CD1D is the human gene that encodes the protein CD1d,[1] a member of the CD1 (cluster of differentiation 1) family of glycoproteins expressed on the surface of various human antigen-presenting cells. They are non-classical MHC proteins, related to the class I MHC proteins, and are involved in the presentation of lipid antigens to T cells. CD1d is the only member of the group 2 CD1 molecules.
Biological significance
CD1d-presented lipid antigens activate a special class of T cells, known as natural killer T (NKT) cells, through the interaction with the T-cell receptor present on NKT membranes.[1] When activated, NKT cells rapidly produce Th1 and Th2 cytokines, typically represented by interferon-gamma and interleukin 4 production.
Nomenclature
CD1d is also known as R3G1
Ligands
Some of the known ligands for CD1d are:
- α-galactosylceramide (α-GalCer), a compound originally derived from the marine sponge Agelas mauritanius[2] with no physiological role but great research utility.
- α-glucuronyl- and α-galacturonyl- ceramides, a family of compounds of microbial origin which can be found, for example, on the cell wall of Sphingomonas, a ubiquitous Gram-negative bacterium.[3] The related β-D-glucopyranosylceramide is accumulated in antigen-presenting cells after infection, where it serves to activate invariant NKTs (iNKTs), a special kind of NKT.
- iGb3, a self antigen which has been implied in iNKT selection.[4]
- HS44, a synthetic amino cyclitolic ceramide analogue which has less contact with the TCR, activating iNKTs in a more constrained way than α-GalCer (specially in relation to Th2 cytokines production) and thus being more interesting for therapeutic use.[5]
CD1d tetramers
CD1d tetramers are protein constructs composed of four CD1d molecules joined together and usually fluorescently labelled, used to identify NKT cells or other CD1d-reactive cells. In particular, type I NKT cells and some type II NKT cells are stained by them. A differentiation of these two types can be obtained in human by using an antibody against the TCR Vα24 chain, which is specific of type I NKT cells.[6]
Although they are the most widely used of CD1d oligomers, sometimes CD1d dimers (two units) or pentamers (five units) are used instead.[6]
References
- ↑ 1.0 1.1 "P15813 (CD1D_HUMAN)". Uniprot. Retrieved 1 March 2013.
- ↑ Franck, Richard W. (1 January 2012). "C-Galactosylceramide: Synthesis and Immunology". Comptes Rendus Chimie. 15 (1): 46–56. doi:10.1016/j.crci.2011.05.006. PMC 3293403. PMID 22408579.
- ↑ Bendelac, A; Savage PB; Teyton I (2007). "The Biology of NKT Cells". Annual Review of Immunology. 25 (1): 297–336. doi:10.1146/annurev.immunol.25.022106.141711. PMID 17150027.
- ↑ Zhou, D (August 2006). "The immunological function of iGb3". Current Protein & Peptide Science. 7 (4): 325–33. doi:10.2174/138920306778018007. PMID 16918447.
- ↑ J. Kerzerho; E. Yu; C. M. Barra; E. Alari-Pahissa; E. Girardi; Y. Harrak; P. Lauzurica; A. Llebaria; D. Zajonc; O. Akbari; A. R. Castaño (2012). "Structural and functional characterization of a novel non-glycosidic iNKT agonist with immunomodulatory properties". Journal of Immunology. 188: 2254–2265. doi:10.4049/jimmunol.1103049. PMC 3288653. PMID 22301545.
- ↑ 6.0 6.1 Terabe, Masaki; Berzofsky, Jay A. (2008). "The Role of NKT Cells in Tumor Immunity". Adv Cancer Res. 101: 277–348. doi:10.1016/S0065-230X(08)00408-9. PMC 2693255. PMID 19055947.
Further reading
- Melián A, Beckman EM, Porcelli SA, Brenner MB (1996). "Antigen presentation by CD1 and MHC-encoded class I-like molecules". Curr. Opin. Immunol. 8 (1): 82–8. doi:10.1016/S0952-7915(96)80109-9. PMID 8729450.
- Joyce S (2001). "CD1d and natural T cells: how their properties jump-start the immune system". Cell. Mol. Life Sci. 58 (3): 442–69. doi:10.1007/PL00000869. PMID 11315191.
- Sköld M, Behar SM (2003). "Role of CD1d-Restricted NKT Cells in Microbial Immunity". Infect. Immun. 71 (10): 5447–55. doi:10.1128/IAI.71.10.5447-5455.2003. PMC 201095. PMID 14500461.
- Brigl M, Brenner MB (2004). "CD1: antigen presentation and T cell function". Annu. Rev. Immunol. 22 (1): 817–90. doi:10.1146/annurev.immunol.22.012703.104608. PMID 15032598.
- Stove V, Verhasselt B (2006). "Modelling thymic HIV-1 Nef effects". Curr. HIV Res. 4 (1): 57–64. doi:10.2174/157016206775197583. PMID 16454711.
- Brutkiewicz RR (2006). "CD1d ligands: the good, the bad, and the ugly". J. Immunol. 177 (2): 769–75. doi:10.4049/jimmunol.177.2.769. PMID 16818729.
- Blumberg RS, Terhorst C, Bleicher P, et al. (1991). "Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells". J. Immunol. 147 (8): 2518–24. PMID 1717564.
- Balk SP, Bleicher PA, Terhorst C (1989). "Isolation and characterization of a cDNA and gene coding for a fourth CD1 molecule". Proc. Natl. Acad. Sci. U.S.A. 86 (1): 252–6. doi:10.1073/pnas.86.1.252. PMC 286442. PMID 2463622.
- Calabi F, Jarvis JM, Martin L, Milstein C (1989). "Two classes of CD1 genes". Eur. J. Immunol. 19 (2): 285–92. doi:10.1002/eji.1830190211. PMID 2467814.
- Yu CY, Milstein C (1990). "A physical map linking the five CD1 human thymocyte differentiation antigen genes". EMBO J. 8 (12): 3727–32. PMC 402056. PMID 2583117.
- Martin LH, Calabi F, Milstein C (1987). "Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens". Proc. Natl. Acad. Sci. U.S.A. 83 (23): 9154–8. doi:10.1073/pnas.83.23.9154. PMC 387093. PMID 3097645.
- Balk SP, Burke S, Polischuk JE, et al. (1994). "Beta 2-microglobulin-independent MHC class Ib molecule expressed by human intestinal epithelium". Science. 265 (5169): 259–62. doi:10.1126/science.7517575. PMID 7517575.
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Kawano T, Cui J, Koezuka Y, et al. (1997). "CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides". Science. 278 (5343): 1626–9. doi:10.1126/science.278.5343.1626. PMID 9374463.
- Katabami S, Matsuura A, Chen HZ, et al. (1998). "Structural organization of rat CD1 typifies evolutionarily conserved CD1D class genes". Immunogenetics. 48 (1): 22–31. doi:10.1007/s002510050396. PMID 9601940.
- Somnay-Wadgaonkar K, Nusrat A, Kim HS, et al. (1999). "Immunolocalization of CD1d in human intestinal epithelial cells and identification of a beta2-microglobulin-associated form". Int. Immunol. 11 (3): 383–92. doi:10.1093/intimm/11.3.383. PMID 10221650.
- Campbell NA, Kim HS, Blumberg RS, Mayer L (1999). "The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells". J. Biol. Chem. 274 (37): 26259–65. doi:10.1074/jbc.274.37.26259. PMID 10473580.
- Han M, Hannick LI, DiBrino M, Robinson MA (2000). "Polymorphism of human CD1 genes". Tissue Antigens. 54 (2): 122–7. doi:10.1034/j.1399-0039.1999.540202.x. PMID 10488738.
External links
- CD1d+antigen at the US National Library of Medicine Medical Subject Headings (MeSH)
- Human CD1A genome location and CD1A gene details page in the UCSC Genome Browser.
- Human CD1D genome location and CD1D gene details page in the UCSC Genome Browser.